Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses

Combined vaccine formulations targeting not only hemagglutinin but also other influenza virus antigens could form the basis for a universal influenza virus vaccine that has the potential to elicit long-lasting, broadly cross-reactive immune responses. Lipid nanoparticle (LNP)-encapsulated messenger...

Descripción completa

Detalles Bibliográficos
Autores principales: McMahon, Meagan, O’Dell, George, Tan, Jessica, Sárközy, András, Vadovics, Máté, Carreño, Juan Manuel, Puente-Massaguer, Eduard, Muramatsu, Hiromi, Bajusz, Csaba, Rijnink, Willemijn, Beattie, Mitchell, Tam, Ying K., Kirkpatrick Roubidoux, Ericka, Francisco, Isabel, Strohmeier, Shirin, Kanekiyo, Masaru, Graham, Barney S., Krammer, Florian, Pardi, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659346/
https://www.ncbi.nlm.nih.gov/pubmed/36322769
http://dx.doi.org/10.1073/pnas.2206333119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659346/
https://www.ncbi.nlm.nih.gov/pubmed/36322769
http://dx.doi.org/10.1073/pnas.2206333119

Ejemplares similares